HomeSIGA • NASDAQ
add
SIGA Technologies Inc
Previous close
$5.46
Year range
$4.95 - $9.62
Market cap
391.18M USD
Avg Volume
548.90K
P/E ratio
16.86
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.79M | -95.34% |
Operating expense | 5.26M | -23.81% |
Net income | -5.43M | -111.87% |
Net profit margin | -143.12 | -354.80% |
Earnings per share | — | — |
EBITDA | -9.35M | -116.35% |
Effective tax rate | 31.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 154.97M | -0.28% |
Total assets | 219.47M | -10.18% |
Total liabilities | 20.65M | -27.64% |
Total equity | 198.82M | — |
Shares outstanding | 71.64M | — |
Price to book | 1.96 | — |
Return on assets | -10.53% | — |
Return on capital | -11.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.43M | -111.87% |
Cash from operations | -16.86M | -129.94% |
Cash from investing | -40.54K | -127.26% |
Cash from financing | -87.82K | 45.71% |
Net change in cash | -16.99M | -130.27% |
Free cash flow | -14.02M | -130.92% |
About
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Wikipedia
CEO
Founded
Dec 28, 1995
Website
Employees
49
